Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

531 questions in 102 reviews · Gynaecology and Fertility

current versions
No studies 531 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Natural cycle FET vs HT plus GnRHa suppression FET
Ongoing pregnancy rate per woman · subfertile women
Cycle regimens for frozen‐thawed embryo transfer (2017) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Total adverse effects · women having elective abdominal hysterectomy
Antibiotic prophylaxis for elective hysterectomy (2017) · Cochrane
no estimate extractedNRNo studies
Antibiotics vs placebo
Total adverse effects ‐ not reported · women having elective vaginal hysterectomy
Antibiotic prophylaxis for elective hysterectomy (2017) · Cochrane
no estimate extractedNRNo studies
Glucocorticoid supplementation vs placebo
OHSS per woman · Patients undergoing IVF or ICSI
Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI (2017) · Cochrane
no estimate extractedNRNo studies
Glucocorticoid supplementation vs placebo
Side‐effects per woman · Patients undergoing IVF or ICSI
Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI (2017) · Cochrane
no estimate extractedNRNo studies
NSAID vs placebo
Quality of life: not reported · women with endometriosis
Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis (2017) · Cochrane
no estimate extractedNRNo studies
NSAID vs placebo
Effects on daily activities: not reported · women with endometriosis
Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis (2017) · Cochrane
no estimate extractedNRNo studies
NSAID vs placebo
Absence from work or school: not reported · women with endometriosis
Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis (2017) · Cochrane
no estimate extractedNRNo studies
NSAID vs placebo
Number of women requiring more invasive treatment: not reported · women with endometriosis
Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis (2017) · Cochrane
no estimate extractedNRNo studies
NSAID vs placebo
Participant satisfaction with treatment: not reported · women with endometriosis
Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis (2017) · Cochrane
no estimate extractedNRNo studies
Progestogen vs placebo or no pretreatment
Multiple pregnancy rate (Prog + Ag vs Ag) · ovarian stimulation protocols for women undergoing ART
Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women… (2017) · Cochrane
no estimate extractedNRNo studies
Progestogen vs placebo or no pretreatment
OHSS rate (Prog + Ag vs Ag) · ovarian stimulation protocols for women undergoing ART
Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women… (2017) · Cochrane
no estimate extractedNRNo studies
Progestogen vs placebo or no pretreatment
OHSS rate (Prog + Ant vs Ant) · ovarian stimulation protocols for women undergoing ART
Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women… (2017) · Cochrane
no estimate extractedNRNo studies
Oestrogen vs no pretreatment
Multiple pregnancy rate (Oestr + Ant vs Ant) · ovarian stimulation protocols for women undergoing ART
Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women… (2017) · Cochrane
no estimate extractedNRNo studies
Oestrogen vs no pretreatment
OHSS rate (Oestr + Ant vs Ant) · ovarian stimulation protocols for women undergoing ART
Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women… (2017) · Cochrane
no estimate extractedNRNo studies
Intracervical vs combined intracervical and paracervical anaesthesia
Adverse effects · women undergoing outpatient hysteroscopy
Pain relief for outpatient hysteroscopy (2017) · Cochrane
no estimate extractedNRNo studies
Antispasmodic plus NSAID vs paracervical anaesthesia
Pain score within 30 minutes of the procedure · women undergoing outpatient hysteroscopy
Pain relief for outpatient hysteroscopy (2017) · Cochrane
no estimate extractedNRNo studies
Antispasmodic plus NSAID vs paracervical anaesthesia
Adverse effects · women undergoing outpatient hysteroscopy
Pain relief for outpatient hysteroscopy (2017) · Cochrane
no estimate extractedNRNo studies
LOD 4‐5 vs 2 or fewer punctures
Improvement in androgenic symptoms · Women with symptoms of PCOS
Ovarian surgery for symptom relief in women with polycystic ovary syndrome (2017) · Cochrane
no estimate extractedNRNo studies
LOD 4‐5 vs 2 or fewer punctures
Harms LOD 4 ‐ 5 versus fewer punctures · Women with symptoms of PCOS
Ovarian surgery for symptom relief in women with polycystic ovary syndrome (2017) · Cochrane
no estimate extractedNRNo studies
LOD vs LOD variable energy
Improvement in androgenic symptoms · Women with symptoms of PCOS
Ovarian surgery for symptom relief in women with polycystic ovary syndrome (2017) · Cochrane
no estimate extractedNRNo studies
IUI in natural cycles vs TI
Live birth rate · couples with male subfertility
Assisted reproductive technologies for male subfertility (2016) · Cochrane
no estimate extractedNRNo studies
IUI in stimulated cycles vs TI
OHSS · couples with male subfertility
Assisted reproductive technologies for male subfertility (2016) · Cochrane
no estimate extractedNRNo studies
IUI in stimulated cycles vs IUI
OHSS · couples with male subfertility
Assisted reproductive technologies for male subfertility (2016) · Cochrane
no estimate extractedNRNo studies
IVF vs IUI
OHSS · couples with male subfertility
Assisted reproductive technologies for male subfertility (2016) · Cochrane
no estimate extractedNRNo studies
IUI in natural cycles vs TI
OHSS · couples with male subfertility
Assisted reproductive technologies for male subfertility (2016) · Cochrane
no estimate extractedNRNo studies
Mannitol vs placebo / no treatment
Live birth · women at high risk of OHSS
Volume expanders for the prevention of ovarian hyperstimulation syndrome (2016) · Cochrane
no estimate extractedNRNo studies
Mannitol vs placebo / no treatment
Adverse effects · women at high risk of OHSS
Volume expanders for the prevention of ovarian hyperstimulation syndrome (2016) · Cochrane
no estimate extractedNRNo studies
Human albumin vs placebo or no treatment
Live birth · women at high risk of OHSS
Volume expanders for the prevention of ovarian hyperstimulation syndrome (2016) · Cochrane
no estimate extractedNRNo studies
Human albumin vs placebo or no treatment
Adverse effects · women at high risk of OHSS
Volume expanders for the prevention of ovarian hyperstimulation syndrome (2016) · Cochrane
no estimate extractedNRNo studies
HES vs placebo or no treatment
Live birth · Women at high risk of OHSS
Volume expanders for the prevention of ovarian hyperstimulation syndrome (2016) · Cochrane
no estimate extractedNRNo studies
HES vs placebo or no treatment
Adverse effects · Women at high risk of OHSS
Volume expanders for the prevention of ovarian hyperstimulation syndrome (2016) · Cochrane
no estimate extractedNRNo studies
Oestrogen cream vs other regimens
Endometrial thickness not reported · postmenopausal women with vaginal atrophy
Local oestrogen for vaginal atrophy in postmenopausal women (2016) · Cochrane
no estimate extractedNRNo studies
Dietary supplements vs placebo
Outcomes1 · women with moderate or severe primary dysmenorrhoea
Dietary supplements for dysmenorrhoea (2016) · Cochrane
no estimate extractedNRNo studies
Antioestrogen vs placebo
Live birth rate ‐ not reported · ovulation induction in polycystic ovarian syndrome
Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome (2016) · Cochrane
no estimate extractedNRNo studies
Antioestrogen vs placebo
Miscarriage rate ‐ not reported · ovulation induction in polycystic ovarian syndrome
Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome (2016) · Cochrane
no estimate extractedNRNo studies
Antioestrogen vs placebo
Multiple pregnancy rate ‐ not reported · ovulation induction in polycystic ovarian syndrome
Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome (2016) · Cochrane
no estimate extractedNRNo studies
Antioestrogen vs placebo
Ovarian hyperstimulation syndrome (OHSS) ‐ not reported · ovulation induction in polycystic ovarian syndrome
Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome (2016) · Cochrane
no estimate extractedNRNo studies
Anterior prolapse repair: native tissue vs absorbable mesh
De novo dyspareunia · women with anterior compartment pelvic organ prolapse
Surgery for women with anterior compartment prolapse (2016) · Cochrane
no estimate extractedNRNo studies
Low‐dose aspirin vs placebo or no treatment
Other adverse events · Women with subfertility
Aspirin for in vitro fertilisation (2016) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse effects: Acupressure versus placebo , no treatment or active controls · women with primary dysmenorrhoea
Acupuncture for dysmenorrhoea (2016) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events: Acupuncture versus sham or placebo control · women with primary dysmenorrhoea
Acupuncture for dysmenorrhoea (2016) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events: Acupuncture versus no treatment · women with primary dysmenorrhoea
Acupuncture for dysmenorrhoea (2016) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events and drug reactions · Subfertile women undergoing in vitro maturation
Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation (2016) · Cochrane
no estimate extractedNRNo studies
CHM vs HT
Outcomesa · Women with menopausal symptoms
Chinese herbal medicine for menopausal symptoms (2016) · Cochrane
no estimate extractedNRNo studies
Long protocol (continued same vs reduced dose GnRHa)
Live birth and ongoing pregnancies per woman randomised · women undergoing pituitary suppression in assisted reproduction
Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction (2015) · Cochrane
no estimate extractedNRNo studies
Short protocol vs stop short protocol
Live birth and ongoing pregnancies per woman randomised · women undergoing pituitary suppression in assisted reproduction
Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction (2015) · Cochrane
no estimate extractedNRNo studies
Short vs ultrashort protocol
Live birth and ongoing pregnancies per woman randomised · women undergoing pituitary suppression in assisted reproduction
Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction (2015) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Comparisons** · Women in assisted reproductive technology cycles (ART) receiving human pre‐implantation embryos in either early…
Culture media for human pre‐implantation embryos in assisted reproductive technology cycles (2015) · Cochrane
no estimate extractedNRNo studies
Intervention NR
OHSS ‐ short vs long protocol · subfertile women
Luteal phase support for assisted reproduction cycles (2015) · Cochrane
no estimate extractedNRNo studies